THE NETWORK OF HEMATOPOIETIC CYTOKINES

被引:0
作者
SACHS, L
LOTEM, J
机构
来源
PROCEEDINGS OF THE SOCIETY FOR EXPERIMENTAL BIOLOGY AND MEDICINE | 1994年 / 206卷 / 03期
关键词
D O I
暂无
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Cell viability, multiplication, and differentiation to the various hematopoietic cell lineages are induced by a multigene cytokine family, and hematopoiesis is controlled by a network of interactions between these cytokines. This network includes positive regulators such as colony-stimulating factors and interleukins, and negative regulators such as transforming growth factor-beta and tumor necrosis factor. The functioning of the network requires an appropriate balance between positive and negative regulators, and the selective regulation of programed cell death (apoptosis) by interaction of cytokines with their receptors. The cytokine network, which has arisen during evolution, allows considerable flexibility, depending on which part of the network is activated, and the ready amplification of response to a particular stimulus. This amplification occurs by autoregulation and transregulation of genes for the hematopoietic cytokines. There is also a transregulation by these cytokines of cytokine receptors. In addition to the flexibility of this network, both for response to present day infections and to infections that may develop in the future, a network may also be necessary to stabilize the whole system. The existence of a network and the cytokine-receptor regulation of apoptosis has to be taken into account in the clinical use of cytokines for therapy. Cytokines that regulate hematopoiesis induce the expression of genes for transcription factors. Cytokine signaling through transcription factors can thus ensure the autoregulation and transregulation of cytokine and receptor genes that occur in the network. Interactions between the cytokine network and transcription factors can also ensure production of specific cell types and stability of the differentiated state.
引用
收藏
页码:170 / 175
页数:6
相关论文
共 66 条
[41]   PRODUCTION OF INTERLEUKIN-6 AND ITS RELATION TO THE MACROPHAGE DIFFERENTIATION OF MOUSE MYELOID-LEUKEMIA CELLS (M1) TREATED WITH DIFFERENTIATION-INDUCING FACTOR AND 1-ALPHA,25-DIHYDROXYVITAMIN-D3 [J].
MIYAURA, C ;
JIN, CH ;
YAMAGUCHI, Y ;
TOMIDA, M ;
HOZUMI, M ;
MATSUDA, T ;
HIRANO, T ;
KISHIMOTO, T ;
SUDA, T .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1989, 158 (03) :660-666
[42]  
MORINAGA Y, 1989, J IMMUNOL, V143, P3538
[43]   ROLE OF INTERLEUKIN-6 (IL-6) IN PROTECTION FROM LETHAL IRRADIATION AND IN ENDOCRINE RESPONSES TO IL-1 AND TUMOR-NECROSIS-FACTOR [J].
NETA, R ;
PERLSTEIN, R ;
VOGEL, SN ;
LEDNEY, GD ;
ABRAMS, J .
JOURNAL OF EXPERIMENTAL MEDICINE, 1992, 175 (03) :689-694
[44]  
OTTMANN OG, 1988, J IMMUNOL, V140, P2661
[45]   CONTINUED REQUIREMENT FOR INDUCER FOR DEVELOPMENT OF MACROPHAGE AND GRANULOCYTE COLONIES [J].
PARAN, M ;
SACHS, L .
JOURNAL OF CELLULAR PHYSIOLOGY, 1968, 72 (03) :247-&
[46]   INDUCTION OF CLONES OF NORMAL MAST CELLS BY A SUBSTANCE FROM CONDITIONED MEDIUM [J].
PLUZNIK, DH ;
SACHS, L .
EXPERIMENTAL CELL RESEARCH, 1966, 43 (03) :553-&
[47]   CLONING OF NORMAL MAST CELLS IN TISSUE CULTURE [J].
PLUZNIK, DH ;
SACHS, L .
JOURNAL OF CELLULAR AND COMPARATIVE PHYSIOLOGY, 1965, 66 (3P1) :319-&
[48]  
REIS LFL, 1988, J IMMUNOL, V140, P1566
[49]   AUTOCRINE BETA-RELATED INTERFERON CONTROLS C-MYC SUPPRESSION AND GROWTH ARREST DURING HEMATOPOIETIC-CELL DIFFERENTIATION [J].
RESNITZKY, D ;
YARDEN, A ;
ZIPORI, D ;
KIMCHI, A .
CELL, 1986, 46 (01) :31-40
[50]  
SACHS L, 1990, CANCER-AM CANCER SOC, V65, P2196, DOI 10.1002/1097-0142(19900515)65:10<2196::AID-CNCR2820651006>3.0.CO